Seagull Pharmaceuticals Pvt Ltd, a active private limited company, was established on 21 November 1984 in Naraina Vihar, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1984PTC019357. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹2.89 Cr.
It upholds a compliant status. Employing 453 professional, Its leadership includes Subhash Malhotra (Manager), Rishabh Singhal (Director), Salil Malhotra (Director). Past directors included Subhash Malhotra, Ajay Bansal. It holds no open charges and ₹2.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 305-306 Imperial Tower C Block Community Centre, Naraina Vihar, Delhi, 110028.
U74899DL1984PTC019357
019357
21 November 1984
₹10.00 Cr
₹2.89 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Seagull Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Malhotra | Manager | 12 May 2023 | Current |
| Rishabh Singhal | Director | 30 Sep 2003 | Current |
| Salil Malhotra | Director | 27 Jul 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 11 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seagull Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 11.2% increase. The company also saw a slight decrease in profitability, with a 8.6% decrease in profit. The company's net worth Soared by an impressive increase of 40.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Seagull Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹28,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 2008 | State Bank Of Bikaner & Jaipur | ₹2.00 Cr | Satisfied |
| 22 Dec 2003 | State Bank Of Bikaner & Jaipur | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Seagull Pharmaceuticals has a workforce of 453 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Seagull Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seagull Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Seagull Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Seagull Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Subhash Malhotra was appointed as a Manager was appointed as a Manager on 12 May 2023 & has been associated with this company since 2 years 6 months . was documented.
Progress on A charge registered on 14 Jan 2008 via Charge ID 10085143 with State Bank Of Bikaner & Jaipur was fully satisfied on 15 Nov 2021. was documented.
Progress on A charge with State Bank Of Bikaner & Jaipur of Rs. 2.00 Cr registered on 14 Jan 2008 with Charge ID 10085143 was modified on 11 May 2012. was documented.
Progress on A charge registered on 22 Dec 2003 via Charge ID 80008269 with State Bank Of Bikaner & Jaipur was fully satisfied on 02 Feb 2008. was documented.
The CIN of Seagull Pharmaceuticals Pvt Ltd is U74899DL1984PTC019357.
Seagull Pharmaceuticals Pvt Ltd is headquartered at 305-306 Imperial Tower C Block Community Centre, Naraina Vihar, Delhi, 110028.
Seagull Pharmaceuticals Pvt Ltd was incorporated on 21 November 1984.
The current directors of Seagull Pharmaceuticals Pvt Ltd are
The primary industry of Seagull Pharmaceuticals Pvt Ltd is Manufacturing.
Seagull Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Seagull Pharmaceuticals Pvt Ltd is ₹10.00 Cr, and the paid-up capital is ₹2.89 Cr.
The compliance status of Seagull Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX